Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,052 papers from all fields of science
Search
Sign In
Create Free Account
procathepsin D
Known as:
pro-cathepsin D
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
CATHEPSIN D
Enzyme Precursors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Proteomic profiling of N‐linked glycoproteins identifies ConA‐binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma
Yi-Jun Qi
,
D. Ward
,
+12 authors
Philip J. Johnson
Proteomics
2014
Corpus ID: 26264571
The aim of this study was to identify novel biomarkers for the diagnosis of, and potential therapeutic targets for…
Expand
Review
2010
Review
2010
Procathepsin D and cancer: From molecular biology to clinical applications.
V. Vetvicka
,
A. Vashishta
,
Sujata Saraswat-Ohri
,
J. Větvičková
World Journal of Clinical Oncology
2010
Corpus ID: 37767864
Procathepsin D (pCD) is overexpressed and secreted by cells of various tumor types including breast and lung carcinomas. pCD…
Expand
Review
2009
Review
2009
Pleiotropic effects of cathepsin D.
A. Vashishta
,
S. Ohri
,
V. Vetvicka
Endocrine, Metabolic & Immune Disorders - Drug…
2009
Corpus ID: 34054578
Over the past decades, the paradigm that lysosomal enzymes participate only in non-specific protein degradation during cell death…
Expand
Review
2008
Review
2008
Possible role of procathepsin D in human cancer
A. Vashishta
,
M. Fusek
,
V. Vetvicka
Folia Microbiologica (Prague)
2008
Corpus ID: 25161353
For the past ten years, our research has been focused on elucidating the mechanism by which procathepsin D (pCD) impacts cancer…
Expand
2007
2007
Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
A. Vashishta
,
S. Ohri
,
M. Proctor
,
M. Fusek
,
V. Vetvicka
International Journal of Oncology
2007
Corpus ID: 14449643
Procathepsin D (pCD), a zymogen of lysosomal aspartic peptidase cathepsin D, overexpression is correlated with highly invasive…
Expand
2007
2007
Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer
S. Ohri
,
A. Vashishta
,
M. Proctor
,
M. Fusek
,
V. Vetvicka
Cancer Biology & Therapy
2007
Corpus ID: 25081250
Elevated level of procathepsin D (pCD), a zymogen of lysosomal aspartic proteinase cathepsin D, is associated with highly…
Expand
2007
2007
Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects.
M. Fusek
,
J. Větvičková
,
V. Vetvicka
Journal of Interferon and Cytokine Research
2007
Corpus ID: 20571442
Procathepsin D (pCD) is a major secreted protein in estrogen receptor-positive (ER+) breast cancer cell lines. Several…
Expand
2007
2007
Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines.
S. Ohri
,
A. Vashishta
,
J. Větvičková
,
M. Fusek
,
V. Vetvicka
International Journal of Biological…
2007
Corpus ID: 7376875
1997
1997
Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts
C. Isidoro
,
M. Démoz
,
D. De Stefanis
,
F. Baccino
,
A. Hasilik
,
G. Bonelli
International Journal of Cancer
1997
Corpus ID: 300873
The kinetics of transport and the processing of procathepsin D (proCD), the precursor of a lysosomal aspartyl protease involved…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE